Public statement on the increased risk of serious infection and neutropenia in patients treated concurrently with Kineret (anakinra) and Enbrel (etanercept)
News
Public statement on the increased risk of serious infection and neutropenia in patients treated concurrently with Kineret (anakinra) and Enbrel (etanercept)
Reference Number: EMEA/31631/02
English (EN) (141.63 KB - PDF)
First published: Last updated: